A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with renal cell carcinoma Meeting Abstract
| Authors: | Lee, C. H.; Makker, V.; Rasco, D.; Taylor, M.; Dutcus, C.; Shumaker, R.; Schmidt, E. V.; Stepan, D.; Li, D.; Motzer, R. J. |
| Abstract Title: | A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with renal cell carcinoma |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx371.002 |
| Language: | English |
| ACCESSION: | WOS:000411324002038 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx371.002 |
| Notes: | Meeting Abstract: 847O -- Appears on pages 295-296 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
